disclosures tackling pain managementtackling pain management a multimodal approach noah nesin, md,...
TRANSCRIPT
2/20/17
1
TACKLING PAIN MANAGEMENT A Multimodal Approach
Noah Nesin, MD, FAAFP VP of Medical Affairs, PCHC Felicity Homsted, PharmD, BCPS Chief Pharmacy Officer, PCHC
DISCLOSURES
Dr. Homsted serves as a 340B Program Subject Matter Expert for the Apexus 340B Prime Vendor Program
GENESIS OF THE OPIATE CRISIS
“Pain as the 5th Vital Sign” will likely become the Bloodletting of the 21st century
• A widely-adopted practice intended to improve care causing a cascade of unanticipated harm
CONTROLLED SUBSTANCE STEWARDSHIP:
A coordinated effort to promote the appropriate use of controlled substances, improve patient outcomes, reduce misuse and abuse, and decrease patient morbidity and mortality attributed to these high-risk medications.
Adapted from APIC definition of antimicrobial stewardship by KariLynn Dowling PharmD.
ACUTE VS. CHRONIC PAIN
Acute • Severity closely associated with tissue
damage
• Emotional component • Pain scales validated
• Low risk of addiction
• WHO ladder approach well studied • Processed in pain matrix
• Amenable to pharmacologic and non-pharmacologic treatment aimed at tissue damage
• Dose dependent risk of overdose
Chronic • Severity unrelated to tissue
damage • EMOTIONAL COMPONENT • Pain scales not validated • Significant risk of addiction • WHO ladder approach not
studied at all • Processed in emotion/reward
areas of brain • Dose dependent risk of
overdose
PUBLIC HEALTH APPROACH
Between 2000 - 2016 • Prescription opioid overdose deaths in US increase 265% in men, 400% in women
• Maine leads nation in prescribing long acting opioids @ 21.8 Rx/100 people
• 60 to 65 pills for every man woman and child in Maine annually
• Opioid overdose deaths in Maine are now at 1 a day
• Over 1000 babies born with NAS in Maine each year
• More than half the crime in Maine is drug related
• Dramatically increased need for family support services and child protective intervention
• 16,000 Mainers on > 100 MME daily for chronic pain
• 28,000 Mainers with OUD with capacity to treat 3500 to 7000
• NIH estimates 70% of people with chronic pain receive improper treatment
2/20/17
2
NUMBER NEEDED TO KILL & ABUSE RATES
• NNK 550 for any dose of chronic opioid
• NNK 32 for >200 MME
• Lifetime prevalence of OUD for people on daily opioids for chronic pain is 35% • 0.35 x 16,000 = 5600
• May be higher due to adverse selection
• Almost certain to be a very high percentage of people taking it for psychological reasons
• Very high prevalence of trauma/PTSD
SOME INTERESTING NUMBERS
• Start an opioid today, 1 in 15 chance of being on it a year from now
• NNT 4.6 for post op pain using 15 mg oxycodone • NNT 1.6 for post op pain using Ibuprofen 200 mg + APAP
500 mg • 66% of pills abused by adolescents come from friend or
family
OVER-PRESCRIBING
• Over-prescribing for wisdom tooth extractions leads to 100 million excess doses/year
• Orthopedic day surgery patients receive an average of 30 opioid pills and take an average of 11
• 80% of C-section patients report taking less than half of prescription, >50% report taking none
• 70% of thoracic surgery patients report taking less than half of prescription, 40% report taking none
• Almost everybody keeps their excess pills
REMEMBER HOW WE GOT HERE
1. Opioids promoted as gold standard of treatment for chronic pain • no evidence to support that claim
2. No ceiling dose • no evidence to support that claim
3. Very low (<1%) risk of addiction when opioids used for chronic pain • no evidence to support that claim
4. Consider “pseudoaddiction” to explain alarm behaviors • no evidence to support that claim
RESPONSE TO PRESCRIPTION DRUG CRISIS
Education
Treatment
Prevention Harm Reduction
An interdisciplinary controlled substance review process was implemented in February 2013 with the goal of decreasing
inappropriate prescribing of opioids and the associated patient morbidity and mortality.
Enforcement
2/20/17
3
CSI PROGRAM OVERVIEW
Controlled Substance Initiative (CSI) Committee
Chief medical officer, chief psychiatrist, pharmacy residents, physicians, mid-level
practitioners, and care managers
Provider-patient controlled substance
agreements
Controlled substance policies with provisions for
oversight
Proactive case reviews based on referrals and QI
reports
Pharmacist-driven, resident-managed array of clinical and administrative services
CSI IMPACT
• Retrospective chart review: 93 cases involving opioids reviewed in a 90-day period5
• Dose reductions suggested in 78 cases • At three-month follow-up, 76% of dose reductions
implemented • 32% of patients had the prescription eliminated completely
• Overall: 60% reduction in opiate and benzo prescriptions organization wide
• Ongoing research: premature deaths (<60 years) involving opioids • Preliminary results: 50% decrease between 2013 and
2015
PATIENTS ON CHRONIC OPIOID PRESCRIPTIONS
1340
1253 1137
1320 1379
1112 1057 1035
1282
909
803
630
0
200
400
600
800
1000
1200
1400
1600
Oc
t-13
No
v-13
De
c-1
3
Jan
-14
Feb
-14
Ma
r-14
Ap
r-14
Ma
y-14
Jun
-14
Jul-1
4
Au
g-1
4
Sep
-14
Oc
t-14
No
v-14
De
c-1
4
Jan
-15
Feb
-15
Ma
r-15
Ap
r-15
Ma
y-15
Jun
-15
Jul-1
5
Au
g-1
5
Sep
-15
Oc
t-15
No
v-15
De
c-1
5
Jan
-16
Feb
-16
Ma
r-16
Ap
r-16
Ma
y-16
Jun
-16
Jul-1
6
Au
g-1
6
Sep
-16
Oc
t-16
PATIENTS ON CHRONIC BENZODIAZEPINE PRESCRIPTIONS
799
750
683
592
525
470
321
0
100
200
300
400
500
600
700
800
900
Feb
-14
Ma
r-14
Ap
r-14
Ma
y-14
Jun
-14
Jul-1
4
Au
g-1
4
Sep
-14
Oc
t-14
No
v-14
De
c-1
4
Jan
-15
Feb
-15
Ma
r-15
Ap
r-15
Ma
y-15
Jun
-15
Jul-1
5
Au
g-1
5
Sep
-15
Oc
t-15
No
v-15
De
c-1
5
Jan
-16
Feb
-16
Ma
r-16
Ap
r-16
Ma
y-16
Jun
-16
Jul-1
6
Au
g-1
6
Sep
-16
Oc
t-16
PREMATURE DEATHS WITH OPIOID USE
55
41
28
0
10
20
30
40
50
60
2013 2014 2015
OTHER TREATMENTS
2/20/17
4
ALTERNATIVE TREATMENT CONSIDERATIONS
• Trauma informed care/ ACEs
• EMDR (in PTSD)
• CBT
“BUT NOTHING ELSE WORKS”
• Antidepressants
• Anticonvulsants
• NSAID
• Counseling
• Physical Therapy
• Manipulation
• Support Groups
• Exercise
• Weight Loss
• Acupuncture
• Massage
• Chiropractic
• Tai Chi
• Mindfullness
• Yoga
PCHC EXPERIENCE:
• Provider impact
• Practice security
• New addiction focus
• Awareness of suffering
IMPACT ON THE HOUSEHOLD & COMMUNITY
• Controlled Substance Initiative
• HRSA Substance Abuse Expansion Grant
• Rapid Access Suboxone Treatment Center
• NAS outpatient treatment clinic
• Naltrexone pilot for women released from county jail
• Partner in MCPC, Caring for ME, MICIS, Maine Opiate Collaborative
• CHLB/ BACSWG
A PATH FORWARD
The Island of Opioids
Reduce pain related distress, disability and suffering. Offer empathy, encouragement, mentorship, hope.
2/20/17
5
Time
Role of Emotion
in the Intensity
of Chronic
Pain
Insight
Emotional/ Psychosocial
Factors
Suffering
NOAH’S UNOFFICIAL AND LIKELY DERIVATIVE CHRONIC PAIN AND
SUFFERING PRINCIPLE WHAT RESPONDING TO SUFFERING REQUIRES
• Engagement as a whole person
• Emotional intelligence
• Self-awareness
• Sense of purpose
• Humility
• Patience
“RESPONDING TO SUFFERING”
EPSTEIN AND BACK, JAMA, DEC. 22/29,2015
Diagnosing and Treating • Identify a problem and propose a treatment to restore
health and normal function o Tests, referrals, procedures, surgeries, meds o Do something!
• May lead to frustration or sense of inadequacy in managing chronic pain
• Our own emotional reactions may intrude • Distancing
o More referrals o Longer appointment intervals o Blame the patient
RESPONDING TO SUFFERING
Turning Toward • Recognize suffering
• Ask for the story
• Be present
• Honor their experience
• Recognize their strength
• Be authentic
• Humility
• Non-abandonment
• Spirituality
• Connection
• Loyalty
• “Sustained compassionate engagement”
Refocusing and Reclaiming
• Help them to access sources of strength and resiliency
• The things that are important • Redefine goals focused on
enhancing meaning • Take back control • Learn from the illness • Integrate their values • Acknowledge ambiguity • Challenge self-perceptions • Hope
“Those who have a why to live, can bear with
almost any how.”
Viktor E. Frankl
Man's Search for Meaning
QUESTIONS?